Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Journal of Clinical Microbiology|April 3, 2020
Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosaChristian M Gill, Maxwell J Lasko, Tomefa E Asempa, et al.BMC Microbiology|July 22, 2020
EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase-producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrationsMaxwell J Lasko, Christian M Gill, Tomefa E Asempa, et al.The Journal of Antimicrobial Chemotherapy|October 22, 2022
In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combinationAndrew J Fratoni, Lindsay M Avery, David P Nicolau, et al.Clinical Transplantation|November 22, 2017
Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipientsTomefa E Asempa, Lorita M Rebellato, Suzanne Hudson, et al.Critical Care Explorations|March 27, 2024
A New Dosing Frontier: Retrospective Assessment of Effluent Flow Rates and Residual Renal Function Among Critically Ill Patients Receiving Continuous Renal Replacement TherapyDamini Lakshmipathy, Xiaoyi Ye, Joseph L Kuti, et al.Microbiology Spectrum|November 24, 2021
Evaluation of Metallo-β-Lactamase Susceptibility Testing in a Physiologic MediumTomefa E Asempa, Hannah Bajor, Jessica H Mullins, et al.Journal of Clinical Microbiology|October 1, 2020
Variability in Zinc Concentration among Mueller-Hinton Broth Brands: Impact on Antimicrobial Susceptibility Testing of Metallo-β-Lactamase-Producing EnterobacteriaceaeAnastasia Bilinskaya, Douglas J Buckheit, Michael Gnoinski, et al.Antimicrobial Agents and Chemotherapy|January 24, 2019
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection ModelTomefa E Asempa, Ana Motos, Kamilia Abdelraouf, et al.International Journal of Antimicrobial Agents|November 10, 2019
Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection modelTomefa E Asempa, Ana Motos, Kamilia Abdelraouf, et al.The Journal of Antimicrobial Chemotherapy|July 31, 2023
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and cliniciansAliaa Fouad, Christian M Gill, Patricia J Simner, et al.Pageof 5